Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Clinical formulations typically incorporate appropriate antioxidant buffers or maintain GHK-Cu concentrations within therapeutic windows (0.1-10 M) to optimize beneficial effects while minimizing pro-oxidant risks
Eur J Clin Pharmacol 56 (3): 247-50 (2000) * Main mechanism of action involves inhibition of nitric oxide synthase and guanylate cyclase
The most commonly reported effects in clinical trials include: These side effects are generally mild to moderate and tend to resolve as the body acclimates to the medication
What to Actually Expect from GHK-Cu Injections Injectable GHK-Cu provides a degree of systemic distribution that topical GHK-Cu products simply cannot match
Kranendijk, M., Struys, E
